The NAPOLI - 1 (NAnoliPOsomaL Irinotecan) Phase 3 study — a final confirmation of a drug's safety and effectiveness — was conducted among patients with metastatic pancreatic cancer who previously received gemcitibine, which has been the standard - of - care therapy for such patients. (sciencedaily.com)
This Research Team is studying CAR T cell immunotherapy in metastatic pancreatic cancer patients, looking for changes in DNA «on and off switches» (epigenetic changes) following treatment with CAR T. (pancreaticcancercollective.org)
In an international randomized phase III trial, patients with metastatic pancreatic cancer who were treated with a combination of albumin - bound paclitaxel (nab - paclitaxel [Abraxane ®]-RRB- and gemcitabine (Gemzar ®) lived longer than patients who were treated with gemcitabine alone. (cancer.gov)